Source:http://linkedlifedata.com/resource/pubmed/id/12519617
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-9
|
pubmed:abstractText |
Oral theophylline has, for many years, been used as a bronchodilator in patients with COPD. Despite the introduction of new drugs, and its narrow therapeutic index, theophylline is still recommended for COPD treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD003902
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12519617-Administration, Oral,
pubmed-meshheading:12519617-Bronchodilator Agents,
pubmed-meshheading:12519617-Humans,
pubmed-meshheading:12519617-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:12519617-Randomized Controlled Trials as Topic,
pubmed-meshheading:12519617-Theophylline
|
pubmed:year |
2002
|
pubmed:articleTitle |
Oral theophylline for chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Department of Physiological Medicine, St George's Hospital Medical School, Level 0, Jenner Wing, Cranmer Terrace, London, UK, SW17 0RE. fram@sghms.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|